Reliance Pharma Fund - Direct (Bonus)

Fund Class : Equity - Pharma
Fund House : Reliance Mutual Fund
Aum(Rs Cr) : 653.56
NAV 19 Feb 2019 153.97 -0.08
(-0.05%)

NAV High-Low (in Rs)

ONE Mth 2720.20
2720.20
52-WEEk 1875.94
2752.02

Trailing Returns

% 1-week 1-Mth 6-Mths 1-Yr 3-Yrs
Schemes - - - 5.92 3.61
Sensex -0.77 -1.73 -6.59 6.09 50.81
Nifty -0.54 -1.57 -7.07 3.62 48.88

Fund Features

Types of Scheme Dividend
Options Equity
Assets Size (Rs in Cr) 653.56 (31 Jan 13)
Inception Date 01 Jan 13
Fund Manager Sailesh Raj Bhan

Investment Details

Minimum Investment 5000.00
Purchase Redemption DAILY
Last Dividend paid (Rs)
Entry Load 0.00%
EXIT Load 1.00.

Fund Activity

   As On 31 Jan 2019
Category Share (%)
Derivatives 0.27
Equity 97.74
Reverse Repo 2.28
› More
   As On 31 Jan 2019
Sector Name Amount
Finance & Investments 2.14
Healthcare 9.29
NA 2.55
Pharmaceuticals - Indian - Bulk Drugs 15.67
Pharmaceuticals - Indian - Bulk Drugs & Formln 58.01
Pharmaceuticals - Multinational 12.63
› More
   As On 31 Jan 2019
Company Name
Divi's Lab. 10.52
Sun Pharma.Inds. 10.43
Aurobindo Pharma 9.56
Dr Reddy's Labs 9.50
Sanofi India 6.70
Cipla 6.66
Syngene Intl. 6.61
Biocon 6.44
› More

Fund DETAILS

Asset Management Co.

Registered Address

Reliance Nippon Life Asset Management Ltd,

Reliance Center 7th Floor South
Wing Off Western Express
Highway Santacruz(E) Mumbai-400055

Phone: 022-33031000/30301111 | Fax: 022-33037662

Email: customer_care@reliancemutual.com

Website: www.reliancemutual.com